Boyle F - Search Results

1

Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy.

Smith K, Winstanley J, Boyle F, O'Reilly A, White M, Antill YC. Smith K, et al. Among authors: boyle f. Support Care Cancer. 2018 Feb;26(2):483-489. doi: 10.1007/s00520-017-3852-z. Epub 2017 Aug 22. Support Care Cancer. 2018. PMID: 28831569

2

Follow up after breast cancer -- views of Australian women.

Brennan M, Butow P, Spillane AJ, Marven M, Boyle FM. Brennan M, et al. Aust Fam Physician. 2011 May;40(5):311-6. Aust Fam Physician. 2011. PMID: 21597552

3

Exploring consent to randomized placebo-controlled clinical trials in oncology.

Tolerton SK, Shaw J, O'Reilly A, Dunn S, Boyle FM. Tolerton SK, et al. Asia Pac J Clin Oncol. 2011 Sep;7(3):300-6. doi: 10.1111/j.1743-7563.2011.01424.x. Asia Pac J Clin Oncol. 2011. PMID: 21884443

4

Breast-cancer adjuvant therapy with zoledronic acid.

Coleman RE, Marshall H, Cameron D, Dodwell D, Burkinshaw R, Keane M, Gil M, Houston SJ, Grieve RJ, Barrett-Lee PJ, Ritchie D, Pugh J, Gaunt C, Rea U, Peterson J, Davies C, Hiley V, Gregory W, Bell R; AZURE Investigators. Coleman RE, et al. N Engl J Med. 2011 Oct 13;365(15):1396-405. doi: 10.1056/NEJMoa1105195. Epub 2011 Sep 25. N Engl J Med. 2011. PMID: 21995387 Free article. Clinical Trial.

5

Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer.

Ribi K, Aldridge J, Phillips KA, Thompson A, Harvey V, Thürlimann B, Cardoso F, Pagani O, Coates AS, Goldhirsch A, Price KN, Gelber RD, Bernhard J; BIG 1-98 Collaborative Group; International Breast Cancer Study Group. Ribi K, et al. Br J Cancer. 2012 May 8;106(10):1618-25. doi: 10.1038/bjc.2012.156. Epub 2012 Apr 24. Br J Cancer. 2012. PMID: 22531635 Free PMC article. Clinical Trial.

6

The FACT-Melanoma quality-of-life instrument: comparison of a five-point and four-point response scale using the Rasch measurement model.

Winstanley JB, Saw R, Boyle F, Thompson J. Winstanley JB, et al. Among authors: boyle f. Melanoma Res. 2013 Feb;23(1):61-9. doi: 10.1097/CMR.0b013e32835c7dd9. Melanoma Res. 2013. PMID: 23262441

7

What are the pertinent quality-of-life issues for melanoma cancer patients? Aiming for the development of a new module to accompany the EORTC core questionnaire.

Winstanley JB, White EG, Boyle FM, Thompson JF. Winstanley JB, et al. Among authors: boyle fm. Melanoma Res. 2013 Apr;23(2):167-74. doi: 10.1097/CMR.0b013e32835e5932. Melanoma Res. 2013. PMID: 23358427

8

A qualitative assessment of psychosocial impact, coping and adjustment in high-risk melanoma patients and caregivers.

Tan JD, Butow PN, Boyle FM, Saw RP, O'Reilly AJ. Tan JD, et al. Melanoma Res. 2014 Jun;24(3):252-60. doi: 10.1097/CMR.0000000000000059. Melanoma Res. 2014. PMID: 24584097

9

Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module.

Winstanley JB, Young TE, Boyle FM, Bergenmar M, Bottomley A, Burmeister B, Campana LG, Garioch JJ, King M, Nikolic DV, van de Poll-Franse LV, Saw R, Thompson JF, White EG; European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group. Winstanley JB, et al. Among authors: boyle fm. Melanoma Res. 2015 Feb;25(1):47-58. doi: 10.1097/CMR.0000000000000122. Melanoma Res. 2015. PMID: 25325247

10

Supportive care needs and preferences of lung cancer patients: a semi-structured qualitative interview study.

Brown NM, Lui CW, Robinson PC, Boyle FM. Brown NM, et al. Support Care Cancer. 2015 Jun;23(6):1533-9. doi: 10.1007/s00520-014-2508-5. Epub 2014 Nov 14. Support Care Cancer. 2015. PMID: 25394711

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

429 results

Search Page